SCHEMBL20081376

SCHEMBL20081376

CCc1nc2ccc(F)cc2c(=O)n1-c1cccc(F)c1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HPD P32754 2/20 0.49
▸ TDO2 P48775 2/20 0.49
▸ IDO2 Q6ZQW0 2/20 0.49
▸ HDAC1 Q13547 1/20 0.48
▸ HDAC8 Q9BY41 1/20 0.48
▸ HDAC6 Q9UBN7 1/20 0.48
▸ POLB P06746 1/20 0.48
▸ IDO1 P14902 1/20 0.48
▸ USP2 O75604 1/20 0.47
▸ HTR7 P34969 2/20 0.46
▸ TGM2 P21980 1/20 0.45
▸ ESR1 P03372 1/20 0.45
▸ ESR2 Q92731 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ HTR1A P08908 1/20 0.45
▸ DRD2 P14416 1/20 0.45
▸ HTR2A P28223 1/20 0.45
▸ HTR2C P28335 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20081302 0.93 POLB (0.52) TDO2IDO2HDAC1HDAC8HDAC6
SCHEMBL16854205 0.92 HDAC1 (0.55) TDO2IDO2HDAC1HDAC8HDAC6
SCHEMBL22238128 0.90 USP2 (0.59) USP2L3MBTL1
SCHEMBL20081378 0.85 ALOX12 (0.53) TDO2IDO2HDAC1HDAC8HDAC6
SCHEMBL18332822 0.85 POLB (0.65) HPDTDO2IDO2POLBIDO1
SCHEMBL22237904 0.84 PIK3CD (0.50) USP2ESR1ESR2
SCHEMBL20404407 0.84 ESR1 (0.44) USP2TGM2ESR1ESR2
SCHEMBL15819051 0.83 HTR7 (0.45) TDO2IDO2IDO1USP2HTR7
SCHEMBL20081178 0.81 PIK3CD (0.49) ESR1ESR2
SCHEMBL15826375 0.81 HTR7 (0.50) HPDHTR7TGM2HTR1ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3312175-B1 HETEROARYL DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH PI3 KINASES, CONTAINING SAME AS ACTIVE INGREDIENT KOREA RES INST CHEMICAL TECH (KR) 2020-07-22 — — EP disclosed
EP-3312175-A1 HETEROARYL DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH PI3 KINASES, CONTAINING SAME AS ACTIVE INGREDIENT Korea Research Institute of Chemical Technology (KR) 2018-04-25 — — EP disclosed
Send feedback